tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 381 are a BUY (68.04%), 164 are a HOLD (29.29%), 15 are a SELL (2.68%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 56.07% that have a potential upside of 42.85% achieved within 327 days.
Vamil Divan’s has documented 1,080 price targets and ratings displayed on 57 stocks. The coverage is on Healthcare, Financial Services, Technology sectors.
Most recent stock forecast was given on ABBV, AbbVie at 09-Oct-2026.
Analyst best performing recommendations are on ARAV (ARAVIVE).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Feb-2026
$325
$39.36 (13.78%)
$300
Buy Since 05-Feb-2020
$288
$2.36 (0.83%)
$288
17 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 07-Jan-2026
$275
$-10.64 (-3.72%)
$260
17 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$14.36 (5.03%)
$280
18 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 16-Nov-2023
$290
$4.36 (1.53%)
$285
18 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Which stock is Vamil Divan most bullish on?
Which stock is Vamil Divan most reserved on?
What Year was the first public recommendation made by Vamil Divan?
